Your browser doesn't support javascript.
loading
Factors associated with SARS-CoV-2 infection in unvaccinated children and young adults.
Silverberg, Sarah L; Shulha, Hennady P; McMillan, Brynn; He, Guanyuhui; Lee, Amy; Márquez, Ana Citlali; Bartlett, Sofia R; Gill, Vivek; Abu-Raya, Bahaa; Bettinger, Julie A; Cabrera, Adriana; Coombs, Daniel; Gantt, Soren; Goldfarb, David M; Sauvé, Laura; Krajden, Mel; Morshed, Muhammad; Sekirov, Inna; Jassem, Agatha N; Sadarangani, Manish.
Afiliação
  • Silverberg SL; Vaccine Evaluation Center, BC Children's Hospital Research Institute, 950 West 28th Ave Vancouver, V5Z 4H4, Vancouver, BC, Canada.
  • Shulha HP; Division of Infectious Diseases, Department of Pediatrics, University of Toronto, Toronto, ON, Canada.
  • McMillan B; Vaccine Evaluation Center, BC Children's Hospital Research Institute, 950 West 28th Ave Vancouver, V5Z 4H4, Vancouver, BC, Canada.
  • He G; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Lee A; Vaccine Evaluation Center, BC Children's Hospital Research Institute, 950 West 28th Ave Vancouver, V5Z 4H4, Vancouver, BC, Canada.
  • Márquez AC; Experimental Medicine Program, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Bartlett SR; Vaccine Evaluation Center, BC Children's Hospital Research Institute, 950 West 28th Ave Vancouver, V5Z 4H4, Vancouver, BC, Canada.
  • Gill V; Vaccine Evaluation Center, BC Children's Hospital Research Institute, 950 West 28th Ave Vancouver, V5Z 4H4, Vancouver, BC, Canada.
  • Abu-Raya B; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Bettinger JA; Public Health Laboratory, BC Centre for Disease Control, Vancouver, BC, Canada.
  • Cabrera A; Public Health Laboratory, BC Centre for Disease Control, Vancouver, BC, Canada.
  • Coombs D; Vaccine Evaluation Center, BC Children's Hospital Research Institute, 950 West 28th Ave Vancouver, V5Z 4H4, Vancouver, BC, Canada.
  • Gantt S; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Goldfarb DM; Vaccine Evaluation Center, BC Children's Hospital Research Institute, 950 West 28th Ave Vancouver, V5Z 4H4, Vancouver, BC, Canada.
  • Sauvé L; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Krajden M; Vaccine Evaluation Center, BC Children's Hospital Research Institute, 950 West 28th Ave Vancouver, V5Z 4H4, Vancouver, BC, Canada.
  • Morshed M; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Sekirov I; Vaccine Evaluation Center, BC Children's Hospital Research Institute, 950 West 28th Ave Vancouver, V5Z 4H4, Vancouver, BC, Canada.
  • Jassem AN; Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
  • Sadarangani M; Department of Mathematics, University of British Columbia, Vancouver, BC, Canada.
BMC Infect Dis ; 24(1): 91, 2024 Jan 15.
Article em En | MEDLINE | ID: mdl-38225625
ABSTRACT
BACKGROUND AND

OBJECTIVES:

Pediatric COVID-19 cases are often mild or asymptomatic, which has complicated estimations of disease burden using existing testing practices. We aimed to determine the age-specific population seropositivity and risk factors of SARS-CoV-2 seropositivity among children and young adults during the pandemic in British Columbia (BC).

METHODS:

We conducted two cross-sectional serosurveys phase 1 enrolled children and adults < 25 years between November 2020-May 2021 and phase 2 enrolled children < 10 years between June 2021-May 2022 in BC. Participants completed electronic surveys and self-collected finger-prick dried blood spot (DBS) samples. Samples were tested for immunoglobulin G antibodies against ancestral spike protein (S). Descriptive statistics from survey data were reported and two multivariable analyses were conducted to evaluate factors associated with seropositivity.

RESULTS:

A total of 2864 participants were enrolled, of which 95/2167 (4.4%) participants were S-seropositive in phase 1 across all ages, and 61/697 (8.8%) unvaccinated children aged under ten years were S-seropositive in phase 2. Overall, South Asian participants had a higher seropositivity than other ethnicities (13.5% vs. 5.2%). Of 156 seropositive participants in both phases, 120 had no prior positive SARS-CoV-2 test. Young infants and young adults had the highest reported seropositivity rates (7.0% and 7.2% respectively vs. 3.0-5.6% across other age groups).

CONCLUSIONS:

SARS-CoV-2 seropositivity among unvaccinated children and young adults was low in May 2022, and South Asians were disproportionately infected. This work demonstrates the need for improved diagnostics and reporting strategies that account for age-specific differences in pandemic dynamics and acceptability of testing mechanisms.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Pessoas não Vacinadas Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Child / Humans / Infant País/Região como assunto: America do norte Idioma: En Revista: BMC Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Pessoas não Vacinadas Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Child / Humans / Infant País/Região como assunto: America do norte Idioma: En Revista: BMC Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá